Edesa Biotech GAAP EPS of -$0.60 misses by $0.17
at seekingalpha.com (Thu, 13-Aug 4:27 PM)
Edesa Biotech Showcases Promising Data on Paridiprubart for Acute Kidney Injury Ahead of Major European Conference
Market Chameleon (Tue, 19-May 9:58 AM)
